FDA gets more Money
The US Food & Drug Administration's (FDA) budget for the fiscal year (FY) 2018 will be higher than the one for the FY 2017. This was approved by the U.S. Senate Subcommittee on Appropriations. The authority's budget is part of the Agriculture Appropriations Bill and includes 2.8 billion US$ discretionary funding for the FDA. This is 1 million over the FY2017 budget. Including user fee revenues, total FDA funding will be 5.2 billion US$ (which is 491 million US$ above FY2017). The bill also provides 60 million US$ as authorized in the 21st Century Cures Act.
Related GMP News
21.10.2026Switzerland: GMP Compliance by Foreign Manufacturers
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA



